A variety of small-molecule agents capable of inducing such effects are widely prescribed as anti-cancer drugs which in turn increase the population of topoisomerase II (TOP2) breaking complexes, which leads to TOP2-mediated chromosome DNA cleavage and ultimately death of cancer cells [3]. This evidence concerns the gene TOP2A and cancer.